AI assistant
Lifeward Ltd. — Director's Dealing 2023
Sep 19, 2023
35158_dirs_2023-09-19_e6c3ae87-18cb-417a-9631-64529540b6a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ReWalk Robotics Ltd. (RWLK)
CIK: 0001607962
Period of Report: 2023-09-13
Reporting Person: Dykan Jeff (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | Ordinary Shares, par value NIS 0.25 per share | A | 59595 | $0.00 | Acquired | 119157 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares, par value NIS 0.25 per share | 65655 | Indirect |
| Ordinary Shares, par value NIS 0.25 per share | 50000 | Direct |
Footnotes
F1: Represents 59,595 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.
F2: Consists of 50,488 Ordinary Shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 Ordinary Shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 65,655 shares of ReWalk Robotics Ltd.